Recombinant CD19 Glycomutant Accurately and Reproducibly Detects CD19-Directed CAR-T Cells By Flow Cytometry

被引：1
|
作者：
Kirchmeier, Delaney R. [1 ]
Sheih, Alyssa [2 ,3 ]
Fiorenza, Salvatore [3 ]
Hirayama, Alexandre V. [3 ]
Chou, Cassie [3 ,4 ]
Kimble, Erik [3 ,5 ]
Gauthier, Jordan [3 ]
Williams, Alison [3 ]
Price, Jason [3 ]
Correnti, Colin [3 ,6 ]
Turtle, Cameron J. [3 ,5 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[2] Umoja Biopharma, Seattle, WA USA
[3] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] Univ Washington, Dept Med, Seattle, WA USA
[6] Link Immunotherapeut, Seattle, WA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148229
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1724
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Getting CD19 Into Shape: Expression of Natively Folded "Difficult-to- Express" CD19 for Staining and Stimulation of CAR-T Cells
    Lobner, Elisabeth
    Wachernig, Anna
    Gudipati, Venugopal
    Mayrhofer, Patrick
    Salzer, Benjamin
    Lehner, Manfred
    Huppa, Johannes B.
    Kunert, Renate
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8 (08):
  • [22] Tandem CD19/CD22 Dual Targets CAR-T Cells Therapy Obtains Superior CR Rate Than Single CD19 CAR-T Cells Infusion As Well As Sequential CD19 and CD22 CAR-T Cells Infusion for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients
    Liu, Sining
    Zhang, Xinyue
    Dai, Haiping
    Cui, Qingya
    Cui, Wei
    Yin, Jia
    Li, Zheng
    Xue, Shengli
    Yang, Chunxiu
    Yang, Xiao
    Qiu, Huiying
    Miao, Miao
    Chen, Suning
    Jin, Zhengming
    Fu, Chengcheng
    Li, Caixia
    Sun, Aining
    Han, Yue
    Wang, Ying
    Yu, Lei
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2021, 138
  • [23] CAR T cells: Building on the CD19 paradigm
    Globerson-Levin, Anat
    Riviere, Isabelle
    Eshhar, Zelig
    Sadelain, Michel
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 (09) : 2151 - 2163
  • [24] CAR T cells specific for CD19 can be redirected to kill CD19 negative tumors
    Ambrose, Christine
    Su, Lihe
    Wu, Lan
    Lobb, Roy R.
    Rennert, Paul D.
    CANCER RESEARCH, 2017, 77
  • [25] Extracellular Vesicles Expressing CD19 Antigen Improve Expansion and Efficacy of CD19-Targeted CAR-T Cells
    Zhang, Yuanyuan
    Ge, Tong
    Huang, Meijuan
    Qin, Yun
    Liu, Tianjiao
    Mu, Wei
    Wang, Gaoxiang
    Jiang, Lijun
    Li, Tongjuan
    Zhao, Lei
    Wang, Jue
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 49 - 63
  • [26] Automated Generation and Phenotypic Characterization of Clinical Grade CD19 CAR-T Cells
    Sharma, Ashish
    Roe, Anne
    Lopes, Filipa Blasco
    Liu, Ruifu
    Reese, Jane
    Ribeiro, Susan Pereira
    Sekaly, Rafick-Pierre
    de Lima, Marcos
    Wald, David
    BLOOD, 2018, 132
  • [27] Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia
    Anderson, Nathaniel D.
    Birch, Jack
    Accogli, Theo
    Criado, Ignacio
    Khabirova, Eleonora
    Parks, Conor
    Wood, Yvette
    Young, Matthew D.
    Porter, Tarryn
    Richardson, Rachel
    Albon, Sarah J.
    Popova, Bilyana
    Lopes, Andre
    Wynn, Robert
    Hough, Rachael
    Gohil, Satyen H.
    Pule, Martin
    Amrolia, Persis J.
    Behjati, Sam
    Ghorashian, Sara
    CANCER RESEARCH, 2024, 84 (17)
  • [28] Host B cells escape CAR-T immunotherapy by reversible downregulation of CD19
    Sara Fioretti
    Courtney A. Matson
    Kenneth M. Rosenberg
    Nevil J. Singh
    Cancer Immunology, Immunotherapy, 2023, 72 : 257 - 264
  • [29] Should CD19 CAR-T Cells for ALL be Followed by Allogeneic Stem Cell
    Ramos, Carlos A.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (01): : 1 - 2
  • [30] Host B cells escape CAR-T immunotherapy by reversible downregulation of CD19
    Fioretti, Sara
    Matson, Courtney A.
    Rosenberg, Kenneth M.
    Singh, Nevil J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (01) : 257 - 264
12345